Skip to main content
. 2022 Apr 19;11(9):2282. doi: 10.3390/jcm11092282

Table 1.

Descriptive statistics in 7152 study participants according to blood hypertension.

Variables No Hypertension (n = 5113) Hypertension (n = 2039)
Sex, n (%)
  Male 1891 (37.0) 729 (35.8)
  Female 3222 (63.0) 1310 (64.2)
Age, n (%)
  30–39 1165 (22.8) 26 (1.3)
  40–49 1231 (24.1) 142 (7.0) **
  50–59 1119 (21.9) 392 (19.2) **
  60–69 932 (18.2) 699 (34.3) **
  70–79 525 (10.3) 613 (30.1) **
  ≥80 141 (2.8) 167 (8.2) **
Body mass index, n (%)
  <25 kg/m² 2973 (58.1) 874 (42.9)
  25–29 kg/m² 1583 (31.0) 804 (39.4) **
  ≥30 kg/m² 557 (10.9) 361 (17.7) **
Smoke, n (%)
  Never smoker 2683 (52.5) 1094 (53.7)
  Former smoker 218 (4.3) 111 (5.4) *
  Current smoker 2212 (43.3) 834 (40.9)
Dyslipidemia, n (%)
  No 4758 (93.1) 1576 (77.3)
  Yes 355 (6.9) 463 (22.7) **
Diabetes, n (%)
  No 4871 (95.3) 1649 (80.9)
  Yes 242 (4.7) 390 (19.1) **
History of H. pylori infection #, n (%)
  No 4972 (97.2) 1977 (97.0)
  Yes 141 (2.8) 62 (3.0)
H. pylori status, n (%)
  No infection 2296 (44.9) 837 (41.0)
  Long-lasting H. pylori infection § 1254 (24.5) 607 (29.8) **
  Current H. pylori infection 1563 (30.6) 595 (29.2)

* p < 0.05; ** p < 0.01; # A positive clinical history of H. pylori infection, successfully eradicated, without evidence of the bacteria and/or chronic-active gastritis on histological specimens. § Presence of H. pylori infection associated with atrophy/metaplasia/dysplasia was interpreted as a long-lasting infection. Presence of chronic-active gastritis in addition to the bacteria on gastric specimens.